Hong Woon Yang

USPTO Granted Patents = 17 (Patent Applications = 5)

CIPO Patents = 4

EPO Patents = 12 (Patent Applications = 10)

Average Co-Inventor Count = 5.7

ph-index = 7

Forward Citations = 117(Granted Patents)

Location History:

Baltimore, MD (US) (2007)
Superior, CO (US) (2007 - 2012)
Boulder, CO (US) (2012 - 2017)

Company Filing History:

Ventirx Pharmaceuticals, Inc.

The Johns Hopkins University

where one patent can have more than one assignee

Years Active: 2007-2017

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9718796 - Substituted benzoazepines as toll-like receptor modulators (2017-08-01),

2. 8691809 - Substituted benzoazepines as toll-like receptor modulators (2014-04-08),

3. 8314090 - Methods of synthesis of benzazepine derivatives (2012-11-20),

4. 8299076 - Crystalline forms of 2-(2-flouro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide (2012-10-30),

5. 8211920 - 6-oxo-1,6-dihydropyridine derivatives as inhibitors of MEK and methods of use thereof (2012-07-03),

6. 8106035 - [object Object] (2012-01-31),

7. 8101611 - Substituted pyridazines inhibitors of MEK (2012-01-24),

8. 7893065 - Heterocyclic inhibitors of MEK and methods of use thereof (2011-02-22),

9. 7772234 - Bicyclic inhibitors of MEK and methods of use thereof (2010-08-10),

10. 7732616 - Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof (2010-06-08),

11. 7598383 - Heterocyclic inhibitors of MEK and methods of use thereof (2009-10-06),

12. 7576072 - Heterocyclic inhibitors of MEK and methods of use thereof (2009-08-18),

13. 7538120 - Method of treating inflammatory diseases (2009-05-26),

14. 7517994 - Heterocyclic inhibitors of MEK and methods of use thereof (2009-04-14),

15. 7485643 - Bicyclic inhibitors of MEK and methods of use thereof (2009-02-03),

Title: Innovations by Hong Woon Yang: A Patent-Packing Pioneer from Superior, CO

Introduction: Hong Woon Yang is an accomplished inventor based in Superior, Colorado, with a remarkable portfolio of 17 patents. His innovations primarily focus on medical applications, especially in the modulation of immune responses. Yang’s work has the potential to significantly impact the treatment of various diseases, showcasing his expertise in biopharmaceutical research.

Latest Patents: Among his latest contributions to the field are patents related to substituted benzoazepines as Toll-like receptor modulators. These compositions and methods specifically target the modulation of signaling through Toll-like receptors TLR7 and/or TLR8. The applications of these inventions are extensive, offering promising solutions for treating or preventing several diseases, including cancer, autoimmune diseases, fibrotic diseases, cardiovascular disorders, infectious diseases, inflammatory disorders, graft rejection, and graft-versus-host disease.

Career Highlights: Hong Woon Yang has built a distinguished career in the biopharmaceutical industry. He has played a significant role in leading-edge research and innovation while being employed at notable companies such as Array Biopharma Inc. and Ventirx Pharmaceuticals, Inc. His experience spans both laboratory research and application development, highlighting his versatility in the field.

Collaborations: Throughout his career, Yang has collaborated with esteemed colleagues, including Eli M. Wallace and Joseph P. Lyssikatos. These collaborations have fostered a rich exchange of ideas and expertise, contributing to the advancement of innovative treatments and research initiatives.

Conclusion: Hong Woon Yang's contributions as an inventor have placed him at the forefront of medical innovation. With an impressive portfolio of patents, his work continues to hold promise for the future of disease treatment and prevention. Through his collaborations and career achievements, Yang sets a strong example of how dedicated inventors can shape the landscape of healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.